4.9 (619) In stock
Nature：非小细胞肺癌新靶点CLIP1-LTK被发现，劳拉替尼效果不错@MedSci
Pharos : Target Details - LTK
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung
Molecular Profiling of Circulating Tumour Cells Identifies Notch1
Combinatorial tumor suppressor inactivation efficiently initiates
EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates - Sentana-Lledo - Translational Lung Cancer Research
Tadashi Manabe MD, PhD on X: A whole new oncogenic driver in non-small-cell lung cancer found by the LC-SCRUM Asia. Very very impressive! / X
LC-SCRUMによる新規非小細胞肺癌ドライバーの同定／ゲノム編集による治療を臓器特異的，病態特異的に届ける／コロナワクチン免疫の経時的な減衰
Frontiers Recent progress in targeted therapy for non-small cell
Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect
ROS1-dependent cancers — biology, diagnostics and therapeutics
IJMS, Free Full-Text
Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver
医药前沿nature发文：CLIP1-LTK 融合基因-非小细胞肺癌的新治疗靶点医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung
